콜마비앤에이치
Financials
Valuation Metrics
콜마비앤에이치's Market Cap is ₩2536B. At end of 2025 it was ₩3765B. Ranked #710 of 2,436 in KR market (top 29%), #301 of 1,649 on KOSDAQ (top 18%), #18 of 57 in Household & Personal Products (top 32%) by Market Cap.
Investment Metrics(as of 2026-08-04)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | 253.56B KRW | KR#710/2,436 Sec#18/57 |
| Revenue | 575.05B KRW | KR#563/2,436 Sec#12/57 |
| Net Income | -1.73B KRW | KR—/2,436 Sec—/57 |
| Total Assets | 593.58B KRW | KR#663/2,436 Sec#11/57 |
| Net Assets | 377.34B KRW | KR#602/2,436 Sec#10/57 |
| Employees | 528 | KR#467/2,436 Sec#10/57 |
| Value | ||
| P/B | 0.67x | KR#1,107/2,436 Sec#21/57 |
| P/S | 0.44x | KR#841/2,436 Sec#9/57 |
| EV/EBITDA | 8.89x | KR#526/2,436 Sec#11/57 |
| FCF Yield | 8.86% | KR#663/2,436 Sec#11/57 |
| Profitability | ||
| ROE | -0.46% | KR#1,524/2,436 Sec#35/57 |
| ROA | -0.29% | KR#1,525/2,436 Sec#35/57 |
| Op. Margin | 5.81% | KR#820/2,436 Sec#24/57 |
| Revenue Growth | 0.12% | KR#1,430/2,436 Sec#37/57 |
| Earnings Growth | 1450.97% | KR#48/2,436 Sec#2/57 |
| Financial Health | ||
| Debt Ratio | 157.31% | KR#1,285/2,436 Sec#36/57 |
| Total Debt | 146.18B KRW | KR#588/2,436 Sec#11/57 |
| FCF | 22.45B KRW | KR#485/2,436 Sec#12/57 |
| Cash | 102.74B KRW | KR#457/2,436 Sec#11/57 |
| Current Ratio | 2.29x | KR#822/2,436 Sec#25/57 |
| Net Debt/EBITDA | 1.30x | KR#833/2,436 Sec#25/57 |
| Dividend | ||
| Div. Yield | 0.93% | KR#1,165/2,436 Sec#29/57 |
| Div. Growth | -75.65% | KR—/2,436 Sec—/57 |
| Performance | ||
| 1Y Return | -39.42% | KR#1,828/2,436 Sec#40/57 |
| 1M Return | 2.01% | KR#684/2,436 Sec#28/57 |
| From 52W High | -57.54% | KR#1,594/2,436 Sec#44/57 |
| 1Y MDD | -55.99% | KR#1,207/2,436 Sec#33/57 |
| Trading | ||
| Volume | 71,211 shares | KR#1,137/2,436 Sec#27/57 |
| Foreign Own. | 4.66% | KR#836/2,436 Sec#17/57 |
| Per Share | ||
| EPS | -60 KRW | KR—/2,436 Sec—/57 |
| BPS | 13,279 KRW | KR#737/2,436 Sec#18/57 |
Company Info
Established in 2004, this company specializes in research and development of health functional food and cosmetic materials, listed on KOSDAQ in 2015. It commercializes natural product-based materials to produce health functional foods and cosmetics via ODM/OEM, operating multiple domestic sites and three overseas corporations in China and Australia, along with subsidiaries H&G Co., Ltd. and Geuno Nongrim Co., Ltd. The company supplies diverse products for immune function improvement, gut health improvement, and blood sugar improvement to 26 countries. Kolmar B&H, established in 2014, is headquartered in Jeonui-myeon, Sejong Special Self-Governing City.